GIVOSIRAN vs GLICLAZIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GIVOSIRAN vs GLICLAZIDE: Safety Overview
| Metric | GIVOSIRAN | GLICLAZIDE |
|---|---|---|
| Total FAERS Reports | 1,224 | 5,784 |
| Deaths Reported | 32 | 483 |
| Death Rate | 2.6% | 8.4% |
| Hospitalizations | 595 | 3,195 |
| Average Patient Age | 45.1 yrs | 65.0 yrs |
| % Female Patients | 89.5% | 55.2% |
| FDA Approval Date | Nov 20, 2019 | N/A |
| Manufacturer | Alnylam Pharmaceuticals, Inc. | N/A |
| Route | SUBCUTANEOUS | N/A |
| Marketing Status | Prescription | N/A |